✦ LIBER ✦

Role of XRCC3, XRCC1 and XPD single-nucleotide polymorphisms in survival outcomes following adjuvant chemotherapy in early stage breast cancer patients

✍ Scribed by E. Castro, D. Olmos, A. Garcia, J. J. Cruz…

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Polymorphisms of ERCC1, XPD, XRCC1 and X

✍ Jian Jiang; Jun Liang; Ruyong Yao; Qingfang Li; Shanai Song; Yingying Sun 📂 Article 📅 2009 🏛 Springer-Verlag ⚖ 429 KB

XRCC1 Arg399Gln and RAD51 5′UTR G135C po

✍ Sandra Costa; Daniela Pinto; Deolinda Pereira; Helena Rodrigues; Jorge Cameselle 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 128 KB

PD-010 Pharmacogenetics studies in patie

✍ Giachino, D.; Ghio, P.; Regazzoni, S.; Mandrile, G.; Novello, S.; Selvaggi, G.; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 298 KB

6528 POSTER Role of ERCC1, XRCC3, Aurora

✍ Taron, M.; Cobo, M.; Isla, L.; Massuti, B.; Montes, A.; Sanchez, J.M.; Botia, M. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 62 KB

P-478 CPT-11-docetaxel in untreated pati

✍ Domine, M.; Isla, D.; Cobo, M.; Camps, C.; Batista, N.; Almenarez, J.; Medina, B 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 149 KB

The influence of classical prognostic fa

✍ S Susnjar; I Kezic; Z Neskovic-Konstantinovic; D Gavrilovic; D Nikolic-Vukosavlj 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 319 KB